CHICAGO, June  23, 2026  (GLOBE NEWSWIRE) -- Cosmos Health Inc. (&#34;Cosmos Health&#34; or the &#34;Company&#34;) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has

COSM

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Cosmos Health Deploys AI Call Center to Scale CosmoFarm and Cut Costs

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>CHICAGO, June  23, 2026  (GLOBE NEWSWIRE) -- Cosmos Health Inc. (&amp;#34;Cosmos Health&amp;#34; or the &amp;#34;Company&amp;#34;) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Cosmos Health announced an AI-powered call center deployment for its CosmoFarm subsidiary, tying into its April 2026 AI strategy. The system will handle multilingual calls, routing, and real-time reporting, aiming to boost efficiency and customer experience as revenue growth remains robust across its pharmacy network. The initiative could drive near-term cost savings and support longer-term scalable expansion.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Cosmos Health signs agreement to deploy an AI-powered call center for CosmoFarm.</li><li>AI features include multilingual voice, intelligent call handling, and real-time dashboards.</li><li>CosmoFarm posted record quarterly revenue amid strong pharmacy-network growth.</li><li>April 2026 AI strategy implies potential up to 30% operating-cost reduction in some areas.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Cosmos Health Inc. (COSM)</strong>: Initiating company-wide AI integration to enhance operations and scalability; potential margin impact from cost savings.</li><li><strong>CosmoFarm S.A. (COSM-COFSA (subsidiary; not publicly traded))</strong>: Wholly owned subsidiary deploying AI call center to optimize order intake and support; primary near-term margin driver.</li><li><strong>ZipDoctor, Inc. (Unlisted)</strong>: Former telehealth acquisition; context for Cosmos Health’s broader AI and digital strategy.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. Fits as Cosmos Health discloses a strategic AI deployment and operational improvements expected to influence efficiency and growth trajectory.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>AI-driven call-center rollout could improve CosmoFarm cost structure and service levels.</li><li>Cosmos Health cites up to 30% operating expense reductions in some areas.</li><li>CosmoFarm reported record quarterly revenue, signaling strong demand and scale.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Date of press release: June 23, 2026 (Chicago).</li><li>Cosmos Health Inc. trades on NASDAQ as COSM.</li><li>CosmoFarm S.A. is a wholly owned Cosmos subsidiary deploying the AI call center.</li><li>AI strategy announced in April 2026; potential up to 30% cost reduction in certain processes.</li><li>CosmoFarm recently reported record quarterly revenue with strong transaction volumes.</li><li>AI platform features include multilingual voice assistant, intelligent call handling, outbound automation, backend integration, and real-time dashboards.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bullish over 6–12 months as AI-driven efficiency and scale lift margins and growth.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>CHICAGO, June  23, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=kCV0OjAFKJg8GjMBbygRJr5jgCnWMi0wIYfGHbCTmicq-5HuS9rIox-NbtxbNUKhGPmXyw_vHdJdH7wSXa4EvypCVHk0hnbAY9sK9sRNWnw=" rel="nofollow" target="_blank"><strong><u>Cosmos Health Inc.</u></strong></a><strong> (&#34;Cosmos Health&#34; or the "Company") </strong><a href="https://www.globenewswire.com/Tracker?data=pDeth34zkc_t47C7aafdFTGY-PDd07mIMNLNkx85AsaHEFDwOVfUGtJopnelCBWyMtpdqCf7zZ3Dmz2XUQO8f1DFmQk67RWZdjnV-HChXDY=" rel="nofollow" target="_blank"><strong><u>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/COSM">COSM</a>)</u></strong></a>, a diversified, vertically integrated global healthcare group, today announced that it has signed an agreement to deploy an Artificial Intelligence (AI)-powered call center to support customer communications, including order intake and routine support functions, marking the latest step in the Company’s ongoing integration of AI across its operations.</p>  <p>Under the agreement, the Company’s wholly owned pharmaceutical distribution subsidiary, CosmoFarm S.A. ("CosmoFarm"), will deploy an AI-powered voice and communications platform to manage and enhance its customer communications. The platform is expected to support inbound and outbound calls through capabilities including a multilingual voice assistant, intelligent call handling, outbound campaign automation, integration with back-end systems, and real-time reporting and dashboards.</p>  <p>CosmoFarm recently reported record quarterly revenue and continued strong growth across its expanding pharmacy network. Its high and growing transaction volumes make scalable, intelligent customer engagement increasingly valuable. By automating routine customer interactions, order intake, and support functions, the AI-powered call center is expected to drive process optimization, cost efficiencies, improved responsiveness, and reduced errors, allowing CosmoFarm to continue scaling efficiently while elevating the overall customer experience.</p>  <p>This initiative builds on Cosmos Health’s broader <a href="https://www.globenewswire.com/Tracker?data=hN6mXuKMSD-IoRzI5IBCw1UmU3CoWXq754FO8MqEits4NHdHGlQEWr_KHvFlfeEeSo_bZ9r0lsOuNdmp4DyWJIOpUAAeqOj4_sB5R_Bqqh2DaOnL_SWZP485mpud3yUdhSYceCkDJvf6qdWY_FpG_UF70MvaHmXu2pk7rVWelom2RGwB2R-9T20Si65FaJvoSvEuNP_xJyiPQXxkAZHDIMBt_hEu8tW06hyFqFtXYrVCD9QgV3-5cov9Upilw3EW" rel="nofollow" target="_blank"><u>AI strategy</u></a>, announced in April 2026. Under that strategy, the Company has been deploying AI-driven solutions across both its front-end operations — including order management and customer relationship handling — and its back-end operations, including warehouse optimization, inventory management, and supply chain processes. In certain areas, the Company believes that AI-driven optimization may reduce specific operating expenses by up to 30%, depending on the process and level of automation.</p>  <p><strong>Greg Siokas, CEO of Cosmos Health, stated: </strong>&#34;Deploying an AI-powered call center to support order intake and customer communications is a natural next step in our AI strategy, using technology to drive process optimization, cost efficiencies, and an improved customer experience. This is expected to deliver meaningful benefits across our operations, particularly within CosmoFarm, where record growth and a rapidly expanding customer base make intelligent automation increasingly valuable. As we continue to integrate AI across our operations, we believe we are building a more efficient, scalable, and competitive business."</p>  <p><strong>About Cosmos Health Inc.</strong></p>  <p align="justify">Cosmos Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/COSM">COSM</a>), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life&#xAE;, Mediterranation&#xAE;, bio-bebe&#xAE;, C-Sept&#xAE; and C-Scrub&#xAE;. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&amp;D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&amp;D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at <a href="https://www.globenewswire.com/Tracker?data=pGXPCzDxKyCAW_O868vFVkx0ZmKfc0-GhkRiLCWf7mRM0wmLErjPpLiD62t8j5UY8Bvwoj0sp5Le1f9yCFi6nYBNFUaDYN6qgz2723YLSc4caMabJc0y7qU2u_DjahVR" rel="nofollow" target="_blank"><u>www.cosmoshealthinc.com</u></a>,<a href="https://www.globenewswire.com/Tracker?data=KY9zyk7R-SkJVknlbewz_T3mzrYNxJAZqp4HqbrbQfpf1I0IU27dqQQEmD5CqRbHbEYosoxDyWd82j8z5YwKmZ8WVU2cx_zr9kIFJUkdapI=" rel="nofollow" target="_blank"> <u>www.skypremiumlife.com</u></a>, <a href="https://www.globenewswire.com/Tracker?data=pGXPCzDxKyCAW_O868vFVmpoBdMKaCUK5QtNseMPwRo_RaLR5BQSMy48wkySQN3qg6tluNAtrIRtlFIBmTw42g==" rel="nofollow" target="_blank"><u>www.cana.gr</u></a>, <a href="https://www.globenewswire.com/Tracker?data=qmux5qmjOD5p-Fubd2DUzGG5ONIlRC8HWDL0MH6uYV7wpyYw8VbSVryPWSWvzb3hRfxfXvIJgYCzHRgJIxbaGYY4RmSQcxoI5dBcJ9Xo8nE=" rel="nofollow" target="_blank"><u>www.zipdoctor.co</u></a>, <a href="https://www.globenewswire.com/Tracker?data=pGXPCzDxKyCAW_O868vFVtn4g6VAzh8cSOv1i8vBenefj67UBUIMwtZuVWV7_7V3GTa5ApfIFFgXqcVLgry6TZHffZ5dbZNkMceHoROE0XY=" rel="nofollow" target="_blank"><u>www.cloudscreen.gr</u></a>, as well as <a href="https://www.globenewswire.com/Tracker?data=Ys8yMM3Z876U6ReA4WzPQsnXyYrPD6SoJ173YcDjck6mCb--5HBrRbLMn2MK9Ywv1ODeSEKEM1H8a9p83yBj7uZBL9H-dHwTVfXfldAN_JA09sahp3n-AwuKV4jFAWn_" rel="nofollow" target="_blank"><u>LinkedIn</u></a> and <a href="https://www.globenewswire.com/Tracker?data=Fe-eRK3R5fFCZuWj2uTpQOIh-iuH3PYXFrBjMhAOdy0ssJvbKv9HckkSr8Ag1v7vrQOAsFuuRE5HrgIvcyQpv7dIHEylZXhfbsyXNLc2yKk=" rel="nofollow" target="_blank"><u>X</u></a>.</p>  <p align="justify"><strong>Forward-Looking Statements</strong><br></br>With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans," and similar expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could," generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine and ongoing conflicts in the Middle East and other regions on the Company’s business, operations, and the economy in general; the Company’s ability to successfully develop and commercialize its proprietary products and technologies; changes in interest rates; changes in foreign currency exchange rates, commodity or other price inflation and deflation; our ability to issue debt on terms and at rates acceptable to us; the impact and expected outcome of investigations, inquiries, claims, and litigation; the challenges of operating in international markets; the adequacy of insurance coverage; the effect of accounting charges and of adopting certain accounting standards; the impact of legal and regulatory changes, including changes to tax laws and regulations; guidance for fiscal 2026 and beyond and financial outlook. Forward-looking statements are based on currently available information and our current assumptions, expectations and projections about future events. You should not rely on our forward-looking statements. These statements are not guarantees of future performance and are subject to future events, risks and uncertainties – many of which are beyond our control, dependent on the actions of third parties, or currently unknown to us – as well as potentially inaccurate assumptions that could cause actual results to differ materially from our historical experience and our expectations and projections. These risks and uncertainties include, but are not limited to, those described from time to time in our periodic reports filed with the SEC and available at the SEC’s website (<a href="https://www.globenewswire.com/Tracker?data=eCp5MMkEj6G_uSAyNBGFIrorIGN9Gpdw0ch_if-cmEoLdKBudhQAYi4TEwF7z_q5hMZUThEgoOKVeTM6T38sfA==" rel="nofollow" target="_blank"><u>www.sec.gov</u></a>). There also may be other factors that we cannot anticipate or that are not described herein, generally because we do not currently perceive them to be material. Such factors could cause results to differ materially from our expectations. Forward-looking statements speak only as of the date they are made, and we do not undertake to update these statements other than as required by law. You are advised, however, to review any further disclosures we make on related subjects in our filings with the Securities and Exchange Commission and in our other public statements.</p>  <p align="justify"><strong>Investor Relations Contact:</strong><br></br>BDG Communications<br></br>cosm@bdgcommunications.com</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTc1MTM1NCM3NjcyNTcwIzIyOTgwOTQ="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/OGZkMjg2MmMtMWE4My00YTlhLWFjZWEtOGQ0NjdjYjQ4ZDMzLTEzMDk2NDQtMjAyNi0wNi0yMy1lbg==/tiny/Cosmos-Health-Inc-.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/29681d62-58aa-4ccf-bad9-cb7ce8ae66e4"><img src="https://ml.globenewswire.com/media/29681d62-58aa-4ccf-bad9-cb7ce8ae66e4/small/cosmos-png.png" border="0" width="150" height="78" alt="Primary Logo"></img></a></p>

Cosmos Health announced an AI-powered call center deployment for its CosmoFarm subsidiary, tying into its April 2026 AI strategy. The system will handle multilingual calls, routing, and real-time reporting, aiming to boost efficiency and customer experience as revenue growth remains robust across its pharmacy network. The initiative could drive near-term cost savings and support longer-term scalable expansion.

cosmos-health-signs-agreement-to-deploy-artificial-intelligence-ai-powered-call-center-to-optimize-order-intake-customer-communications-and-operating-efficiency

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News